Virtus ETF Advisers LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$81,281
-19.7%
40,040
-9.0%
0.05%
-18.3%
Q2 2023$101,255
-10.2%
44,024
+18.4%
0.06%
-3.2%
Q1 2023$112,707
-6.1%
37,197
-27.8%
0.06%
-1.6%
Q4 2022$119,986
+46.3%
51,496
+19.8%
0.06%
+90.9%
Q3 2022$82,000
-29.3%
42,988
+0.7%
0.03%
-23.3%
Q2 2022$116,000
+3.6%
42,675
+14.0%
0.04%
-14.0%
Q1 2022$112,000
-27.3%
37,448
-5.6%
0.05%
-13.8%
Q4 2021$154,000
-31.6%
39,675
-27.2%
0.06%
-81.3%
Q1 2016$225,00054,4710.31%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
COWEN AND COMPANY, LLC 4,331,020$7,882,0001.31%
RTW INVESTMENTS, LP 6,869,281$12,502,0000.35%
A.R.T. Advisors, LLC 14,140$26,0000.04%
Hudson Bay Capital Management LP 975,000$1,774,0000.03%
Secure Asset Management, LLC 10,000$18,0000.01%
OSAIC HOLDINGS, INC. 1,774,935$3,230,0000.01%
FNY Investment Advisers, LLC 9,900$18,0000.01%
Squarepoint Ops LLC 322,225$586,0000.01%
LMR Partners LLP 107,912$196,0000.01%
Virtu Financial LLC 17,147$31,0000.00%
View complete list of ARBUTUS BIOPHARMA CORP shareholders